Logo Logo Logo Logo Logo
  • About
    • About AIGHD
    • History
    • People
    • Partners
    • Fellows
    • Where we work
    • Annual Report
    • Careers
    • Contact
  • Research
    • Research Priorities
    • Joep Lange Chair & Fellows Program
    • Scientific Publications & PhD Theses
    • Research Briefs, Articles & Reports
  • Education
    • Bachelor
    • Masters
    • PhD
    • PhD Defenses
    • Internships
    • Student Testimonials
  • Policy
    • TB Vaccine Roadmap
  • Projects
  • News & Events
    • News
    • Events Calendar
    • INTEREST (HIV) Conference
    • Global Health Symposia
    • Inaugural Lectures
  • About

    • About AIGHD
    • History
    • People
    • Partners
    • Fellows
    • Where we work
    • Annual Report
    • Careers
    • Contact
  • Research

    • Research Priorities
    • Joep Lange Chair & Fellows Program
    • Scientific Publications & PhD Theses
    • Research Briefs, Articles & Reports
  • Education

    • Bachelor
    • Masters
    • PhD
    • PhD Defenses
    • Internships
    • Student Testimonials
  • Policy
    • TB Vaccine Roadmap
  • Projects
  • News & Events

    • News
    • Events Calendar
    • INTEREST (HIV) Conference
    • Global Health Symposia
    • Inaugural Lectures

19 Feb Untangling the cost-effectiveness knot: who is oral antiretroviral HIV pre-exposure prophylaxis really for?

Posted at 00:00h in by AIGHD

Authored by: Hankins Catherine
In: Expert Review of Pharmacoeconomics & Outcomes Research, 2014, Feb 19. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/24552641
http://informahealthcare.com/doi/abs/10.1586/14737167.2014.887447



logo
Contact
AHTC, Tower C4
Paasheuvelweg 25
1105 BP Amsterdam
Netherlands
Email: info@aighd.org
Phone: +31 20 210 3960
Twitter
Tweets by @aighd
QUICK LINKS

Annual Report
INTEREST (HIV) Conference
Vacancies
ANBI
Privacy Statement
Cookie Policy
Portal

© Copyright 2017 Amsterdam Institute for Global Health & Development. All rights reserved.